nnc 711 has been researched along with n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride in 1 studies
| Studies (nnc 711) | Trials (nnc 711) | Recent Studies (post-2010) (nnc 711) | Studies (n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride) | Trials (n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride) | Recent Studies (post-2010) (n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride) |
|---|---|---|---|---|---|
| 112 | 0 | 21 | 72 | 0 | 48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calaza, KC; Guimarães-Souza, EM | 1 |
1 other study(ies) available for nnc 711 and n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride
| Article | Year |
|---|---|
Selective activation of group III metabotropic glutamate receptor subtypes produces different patterns of γ-aminobutyric acid immunoreactivity and glutamate release in the retina.
Topics: Amacrine Cells; Anilides; Animals; Benzhydryl Compounds; Calcium; Chickens; Cyclohexanecarboxylic Acids; Dizocilpine Maleate; GABA Plasma Membrane Transport Proteins; GABAergic Neurons; gamma-Aminobutyric Acid; Glutamic Acid; Nipecotic Acids; Oximes; Phosphoserine; Quinoxalines; Receptors, Metabotropic Glutamate | 2012 |